NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

BioCryst logo
Durham’s BioCryst Pharmaceuticals has landed a new federal contract totaling $44 million and added some $3 million to an existing contract to support the development of galidesivir as a possible COVID-19 treatment.
bluebird bio photo
bluebird bio, a global gene therapy company with a new manufacturing facility in Durham, has unveiled positive results in clinical trials of its treatment for boys with a rare and deadly neurological disorder.
Covidentify feature image for smart watches
News of the first U.S. coronavirus case hit the American public on Tuesday, Jan. 21. For Jessilyn Dunn, PhD, assistant professor in the Departments of Biomedical Engineering and Biostatistics and Bioinformatics at Duke University and director of the Duke BIG IDEAs Lab, the infection in Washington State was a cue to launch a new study⁠—CovIdentify.
APIE logo
RTP's APIE Therapeutics has signed a licensing agreement with RTI International to develop a class of RTI-developed compounds targeting heart failure and lung disease.
BioAgilytix building entry
Durham based BioAgilytix Labs has partnered with Boston’s Brio Systems to launch a platform to provide U.S. employers comprehensive COVID-19 testing programs.
Pairwise Brassica juncea
Durham's Pairwise uses its gene editing technology to harness nutrient-rich, pest-resistant qualities of the leafy green Brassica juncea while diminishing pungent flavor.
IMMVention logo
Durham's IMMvention Therapeutix, which discovers and develops therapies that inhibit inflammation, was one of three finalists in LaunchBio’s Big Pitch competition for the most promising life science or biotech startup in the United States.
Dualogics logo
Durham-based Dualogics has sold its core technology for producing therapeutic antibodies to a Canadian biotechnology company.
Merz US headquarters
Merz Therapeutics, with North American headquarters in Raleigh, has gained a new use for Xeomin, its botulinum toxin therapy.
PharmaVoice cover
Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the 100 most inspiring leaders in the pharmaceutical industry.
G1 logo
G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory milestone for its potential therapy for small cell lung cancer.
T-Line Hernia Mesh -- Deep Blue Medical Advances
T-Line Hernia Mesh, the newest medical advance from Deep Blue Medial Advances, has just received U.S. Food and Drug Administration marketing clearance. 
Alexandria Center for AgTech
UPL, a multinational agriculture company based in India, has opened a global research-and-development hub in Research Triangle Park to develop products for sustainable agriculture in partnership with collaborating companies.
Eva Garland
Eva Garland Consulting, LLC (EGC) is one of the country’s fastest-growing private businesses – for a third year in a row – as other NC life sciences companies also made the list, according to Inc. magazine.
RTI International
Federal health officials have tapped RTI International to join a collaboration tracking COVID-19’s ability to cause severe illness and the effectiveness of proposed treatments.